ANTIKÖRPER GEGEN CSF-1R
European patent · EP3038643 · In force
Register entry
- Publication number
- EP3038643
- Application number
- EP14755668
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 26, 2014
- Published
- Jul 6, 2016
- Granted
- May 1, 2019
- Protection ends at the latest
- Aug 25, 2034
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 39/00 (2006.01)A61P 11/00 (2006.01)A61P 35/00 (2006.01)C07K 16/28 (2006.01)
- Priority
- GB 201315487 30.08.2013
- PCT application
- PCT/EP2014/068050 26.08.2014
- PCT publication
- WO2015/028455 05.03.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 3, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 03.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Dec 11, 2019
Owner
- Owner
- UCB Biopharma SPRL, 60, Allée de la Recherche, 1070 Brussels, Belgium → UCB Biopharma SRL, Allé de la Recherche 60, 1070 Brussels, Belgium
Published in Swissreg on 11.12.2019
- May 1, 2019
Granted
Published in Swissreg on 01.05.2019
Parties
Inventor
Slough, Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.